The majority of patients with NAFLD are asymptomatic or have slightly elevated liver enzymes [mild to moderate increase in alanine aminotransferase (ALT) and gamma glutamine transpeptidase (GGT)] or vague upper abdominal pain. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.